121 related articles for article (PubMed ID: 37793801)
1. Prevalence of human papillomavirus (HPV) types 16 and 18 in cervical cancer in Stockholm, Sweden during 2019-2023 compared to 2003-2008.
Sivars L; Holzhauser S; Ramqvist T; Tham E; Hellman K; Dalianis T
Acta Oncol; 2023 Dec; 62(12):1649-1652. PubMed ID: 37793801
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination.
Du J; Näsman A; Carlson JW; Ramqvist T; Dalianis T
Acta Oncol; 2011 Nov; 50(8):1215-9. PubMed ID: 21726177
[TBL] [Abstract][Full Text] [Related]
3. Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine.
Ährlund-Richter A; Cheng L; Hu YOO; Svensson M; Pennhag AAL; Ursu RG; Haeggblom L; Grün N; Ramqvist T; Engstrand L; Dalianis T; Du J
Front Cell Infect Microbiol; 2019; 9():59. PubMed ID: 30949454
[No Abstract] [Full Text] [Related]
4. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
[TBL] [Abstract][Full Text] [Related]
5. Human papilloma virus (HPV) prevalence upon HPV vaccination in Swedish youth: a review based on our findings 2008-2018, and perspectives on cancer prevention.
Du J; Ährlund-Richter A; Näsman A; Dalianis T
Arch Gynecol Obstet; 2021 Feb; 303(2):329-335. PubMed ID: 33247317
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.
Denny L; Adewole I; Anorlu R; Dreyer G; Moodley M; Smith T; Snyman L; Wiredu E; Molijn A; Quint W; Ramakrishnan G; Schmidt J
Int J Cancer; 2014 Mar; 134(6):1389-98. PubMed ID: 23929250
[TBL] [Abstract][Full Text] [Related]
7. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
[TBL] [Abstract][Full Text] [Related]
8. HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix.
Quint KD; de Koning MN; van Doorn LJ; Quint WG; Pirog EC
Gynecol Oncol; 2010 May; 117(2):297-301. PubMed ID: 20207397
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence and attribution of high-risk HPV in different histological types of cervical cancer].
Wang WP; An JS; Yao HW; Li N; Zhang YY; Ge L; Song Y; Wang MJ; Yuan GW; Sun YC; Huang MN; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):293-300. PubMed ID: 31154709
[No Abstract] [Full Text] [Related]
10. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
[TBL] [Abstract][Full Text] [Related]
11. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix.
Burk RD; Terai M; Gravitt PE; Brinton LA; Kurman RJ; Barnes WA; Greenberg MD; Hadjimichael OC; Fu L; McGowan L; Mortel R; Schwartz PE; Hildesheim A
Cancer Res; 2003 Nov; 63(21):7215-20. PubMed ID: 14612516
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of human papillomavirus, its types and variants].
Gudleviciene Z; Didziapetriene J; Suziedelis K; Lapkauskaite L
Medicina (Kaunas); 2005; 41(11):910-5. PubMed ID: 16333213
[TBL] [Abstract][Full Text] [Related]
13. Cervical intraepithelial neoplasia grade 2 or worse in Galicia, Spain: HPV 16 prevalence and vaccination impact.
Pérez-Castro S; Lorenzo-Mahía Y; Iñarrea Fernández A; Lamas-González MJ; Sarán-Díez MT; Rubio-Alarcón J; Reboredo-Reboredo MC; Mosteiro-Lobato S; López-Miragaya I; Torres-Piñón J; Melón-García S
Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):479-85. PubMed ID: 24274937
[TBL] [Abstract][Full Text] [Related]
14. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
Rosário A; Sousa A; Marinho-Dias J; Medeiros R; Lobo C; Leça L; Coimbra N; Tavares F; Baldaque I; Martins G; Monteiro P; Henrique R; Sousa H
J Med Virol; 2023 Jan; 95(1):e28414. PubMed ID: 36541747
[TBL] [Abstract][Full Text] [Related]
15. The Variable Characteristics of Human Papillomavirus in Squamous Cell Carcinoma and Adenocarcinoma of Cervix in China.
Chen W; Sun H; Molijn A; Zeng L; Kang L; Jenkins D; Zhang S; Cui J; Wu Z; Pirog E; Shen G; Zhang X; Qiao Y;
J Low Genit Tract Dis; 2018 Oct; 22(4):355-361. PubMed ID: 30074955
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and pattern of HPV-16 immunostaining in uterine cervical carcinomas in Ethiopian women: a pilot study.
Rashed MM; Bekele A
Pan Afr Med J; 2011; 8():21. PubMed ID: 22121430
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of human papillomavirus type 16 in Sudanese women diagnosed with cervical carcinoma.
Elhasan LME; Bansal D; Osman OF; Enan K; Farag EABA
J Cancer Res Ther; 2019; 15(6):1316-1320. PubMed ID: 31898666
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus type distribution in invasive cervical cancer in Uganda.
Odida M; de Sanjosé S; Quint W; Bosch XF; Klaustermeier J; Weiderpass E
BMC Infect Dis; 2008 Jun; 8():85. PubMed ID: 18577214
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay.
Berois N; De Cremoux P; Mazal D; Sica A; Cedeira M; Caserta B; Barrios E; Osinaga E; Sastre-Garau X
Int J Gynecol Cancer; 2013 Mar; 23(3):527-32. PubMed ID: 23392403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
